---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-026533"
form_type: "8-K"
ticker: "AKTX"
cik: "0001541157"
company_name: "Akari Therapeutics Plc"
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T13:57:51.980037+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Akari Therapeutics furnishes investor presentation for conferences

## Summary
- Investor presentation furnished as Exhibit 99.1 on December 8, 2025.
- Presentation intended for use at conferences and meetings by company officers.
- No specific financial or pipeline details disclosed in the filing body.
- Filing signed by President and CEO Abizer Gaslightwala.

## SEC filing metadata
- accession: 0001493152-25-026533
- form_type: 8-K
- ticker: AKTX
- cik: 0001541157
- company_name: Akari Therapeutics Plc
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1541157/000149315225026533/0001493152-25-026533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1541157/000149315225026533/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-026533
- JSON: https://secwatch.observer/filing/0001493152-25-026533.json
- Plain text: https://secwatch.observer/filing/0001493152-25-026533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.